News

September 11, 2012 — St. Jude Medical Inc. announced the realignment of its product divisions into two new operating units: the Implantable Electronic Systems Division (IESD) and the...

August 30, 2012 — Implantable devices for treating cardiac arrhythmias, which include implantable cardioverter defibrillators (ICDs), are already underused in parts of Eastern and Central...

August 21, 2012 — Zoll Medical Corp. entered into an agreement to license Inovise Medical Inc.’s ambulatory Audicor technology as part of the advanced patient diagnostics in the LifeVest...

August 3, 2012 — In a bid to help control healthcare costs, on Oct 1, 2012, the Centers for Medicare and Medicaid Services (CMS) will stop paying hospitals for treating potentially avoidable...

ICD, CRT battery life

In the coming years, the continued growth and aging of our population will both increase the demand for treatment with implantable cardiac rhythm devices and stretch our ability to pay for care....

July 23, 2012 — Biotronik announced that the first CRT-D patient has been enrolled in the Biotronik EuroEco Trial — the European Health Economic Trial on Home Monitoring in...

July 11, 2012 — Biotronik, a manufacturer of innovative medical technology, announced that enrollment is now complete for the much anticipated SPIRIT-ICD study, with 503 patients from 37...

Boston Scientific Corporation has closed its acquisition of Cameron Health and, as a result, added to its product portfolio the world's first and only commercially available subcutaneous...

June 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved revised product labeling for Boston Scientific Corp.’s Incepta, Energen, Punctua, Cognis and Teligen...

Current risk stratification paradigms for sudden cardiac arrest (SCA) are designed to identify high‐risk populations based primarily on assessment of left ventricular ejection fraction (LVEF)....

The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology (EP) meeting in the world, Heart Rhythm Society (HRS) 2012 in May, held in...

May 23, 2012 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of its Ellipse...

May 14, 2012 ‑ Boston Scientific Corp. announced extended warranties of up to 10 years, depending on the model, for its Energen and Incepta ...

Initial results from the international Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS (EFFORTLESS) subcutaneous implantable defibrillator (S-ICD Registry shows that the...

 

A study of more than 350 competitive athletes with implantable cardioverter defibrillators (ICDs) from around the world showed for the first time that sports may be safer for this...

May 11, 2012 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of its Assura portfolio of...

May 1, 2012 — Cameron Health Inc. announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel voted 7-1 that sufficient data exists demonstrating the efficacy and...

April 15, 2012 - St. Jude Medical Inc., a global medical device company, announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator (ICD). Designed with feedback from more...

The gloves are off and the fight has begun between St. Jude Medical and Medtronic over clinical data regarding their ...